Parallel Advisors’s SQZ Biotechnologies Company SQZ Stock Holding History

Parallel Advisors’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-74	Closed	-$1K	–	3343
2021 Q2	$1K	Buy	+74	New	+$967	﹤0.01%	2884

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parallel Advisors's SQZ Position: Q3 2021 in Review

Parallel Advisors sold out of SQZ Biotechnologies Company (SQZ) in Q3 2021, closing a stake of 74 shares — an estimated $1K sold.

Parallel Advisors first reported a position in SQZ in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 44 funds tracked by Wall St. Rank hold SQZ as of Q3 2021.

Parallel Advisors reported no remaining SQZ Biotechnologies Company position as of Q3 2021 after selling out during the quarter.
Parallel Advisors sold 74 SQZ Biotechnologies Company shares in Q3 2021, an estimated $1K.
Parallel Advisors first reported a position in SQZ Biotechnologies Company in Q2 2021 and held it in 1 quarter.
Parallel Advisors's SQZ Biotechnologies Company position peaked at $1K in Q2 2021.
44 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2021.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.